✦ LIBER ✦

Topical Imiquimod Treatment for Nodular Basal Cell Carcinomas: An Open-Label Series

✍ Scribed by Amy Huber; John D. Huber; Robert B. Skinner Jr.; Raymond T. Kuwahara; Raashid Haque; Rex A. Amonette

Book ID: 109071763
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 61 KB
Volume: 30
Category: Article
ISSN: 1076-0512
DOI: 10.1111/j.1524-4725.2004.30116.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imiquimod Treatment of Superficial and N

Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma: 12-Week Open-Label Trial

✍ Ketty Peris; Elena Campione; Tamara Micantonio; Georgiana Clare Marulli; Maria C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

An open-label, pilot study examining the

An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma

✍ Jason K Wu; Carol Oh; Geoff Strutton; Greg Siller 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Imiquimod 5% cream for the treatment of

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion

✍ W. Sterry; T. Ruzicka; E. Herrera; A. Takwale; J. Bichel; K. Andres; L. Ding; M. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

## Background: Imiquimod 5% cream has been investigated for non-surgical treatment of superficial and nodular basal cell carcinoma (bcc) tumours. ## Objectives: Two studies were conducted to examine the effect of occlusion at low dosing frequencies on the safety and efficacy of topical imiquimod

Enhancement of methyl-aminolevulinate ph

Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma

✍ Andrew Pye; Sandra Campbell; Alison Curnow 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 381 KB